RAPT Therapeutics
RAPT
#8576
Rank
A$0.23 B
Marketcap
$1.75
Share price
-4.50%
Change (1 day)
-85.58%
Change (1 year)

RAPT Therapeutics (RAPT) - Cash on Hand

Cash on Hand as of December 2024 : A$0.38 Billion

According to RAPT Therapeutics's latest financial reports the company has A$0.38 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

RAPT Therapeutics - Cash on Hand chart (from 2018 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31A$0.37 B59.31%
2023-12-31A$0.23 B-36.29%
2022-12-31A$0.36 B39.91%
2021-12-31A$0.26 B80.39%
2020-12-31A$0.14 B31.21%
2019-12-31A$0.11 B22.04%
2018-12-31A$90.56 M48.79%
2017-12-31A$60.86 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$0.42 B 10.78%๐Ÿ‡บ๐Ÿ‡ธ USA